Matthew K. Fust - Director at Neumora Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
NMRA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew K. Fust since 11/28/2024

Holdings reported by Matthew K. Fust for Neumora Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 20.1K $342K $17.03 Oct 18, 2024 Direct
Stock Option (Right to Buy) 80K May 28, 2025 Direct Common Stock

Transactions reported by Matthew K. Fust for Neumora Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.